Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects

Bone

Volumn 49, Issue 6, 2011, Pages 1279-1289

  Tjhia, Crystal K ^a,b   Odvina, Clarita V ^c   Rao, D Sudhaker ^d   Stover, Susan M ^b   Wang, Xiang ^a   Fyhrie, David P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Atypical fracture; Bisphosphonate; Mechanical properties; Mineral density; Nanoindentation; Severely suppressed bone turnover

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOMECHANICS; BONE BIOPSY; BONE DEFORMATION; BONE DENSITY; BONE HARDNESS; BONE MINERAL; BONE MINERALIZATION; BONE STRUCTURE; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FEMUR SHAFT FRACTURE; FRACTURE; HUMAN; HUMAN TISSUE; ILIAC BONE; LONG TERM CARE; MALE; OSTEOPOROSIS; TISSUE LEVEL; TRABECULAR BONE;

ADULT; AGED; BIOMECHANICS; BIOPSY; BONE AND BONES; BONE DENSITY; BONE REMODELING; CASE-CONTROL STUDIES; ELASTIC MODULUS; HARDNESS; HUMANS; MIDDLE AGED; NANOTECHNOLOGY; OSTEOPOROSIS; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 81355160420     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.09.042     Document Type: Article

References (51)

1. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
2. Abrahamsen B., Eiken P., Eastell R. Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis. J Clin Endocrinol Metab. 2010, 95:5258-5265.
3. Black D.M., Kelly M.P., Genant H.K., Palermo L., Eastell R., Bucci-Rechtweg C., et al. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. N Engl J Med 2010, 362:1761-1771.
4. Girgis C.M., Sher D., Seibel M.J. Atypical femoral fractures and bisphosphonate use. N Engl J Med 2010, 362:1848-1849.
5. Lenart B.A., Lorich D.G., Lane J.M. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008, 358:1304-1306.
6. Lenart B.A., Neviaser A.S., Lyman S., Chang C.C., Edobor-Osula F., Steele B., et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009, 20:1353-1362.
7. Park-Wyllie L.Y., Mamdani M.M., Juurlink D.N., Hawker G.A., Gunraj N., Austin P.C., et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 2011, 305:783-789.
8. Shane E., Burr D., Ebeling P.R., Abrahamsen B., Adler R.A., Brown T.D., et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010, 25:2267-2294.
9. Burr D.B., Forwood M.R., Fyhrie D.P., Martin R.B., Schaffler M.B., Turner C.H. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 1997, 12:6-15.
10. Komatsubara S., Mori S., Mashiba T., Li J., Nonaka K., Kaji Y., et al. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 2004, 19:999-1005.
11. Mashiba T., Hirano T., Turner C.H., Forwood M.R., Johnston C.C., Burr D.B. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000, 15:613-620.
12. Mashiba T., Turner C.H., Hirano T., Forwood M.R., Johnston C.C., Burr D.B. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001, 28:524-531.
13. Mashiba T., Mori S., Burr D.B., Komatsubara S., Cao Y., Manabe T., et al. The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 2005, 23:36-42. Suppl.
14. Odvina C.V., Levy S., Rao S., Zerwekh J.E., Sudhaker Rao D. Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol (Oxf) 2010, 72:161-168.
15. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., Pak C.Y. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005, 90:1294-1301.
16. Stepan J.J., Burr D.B., Pavo I., Sipos A., Michalska D., Li J., et al. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 2007, 41:378-385.
17. Burr D.B., Allen M.R. Low bone turnover and microdamage? How and where to assess it?. J Bone Miner Res 2008, 23:1150-1151. author reply 1152-3.
18. Foldes J., Shih M.S., Parfitt A.M. Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces. J Bone Miner Res 1990, 5:1063-1067.
19. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
20. Oliver W.C., Pharr G.M. An improved technique for determining hardness and elastic-modulus using load and displacement sensing indentation experiments. J Mater Res 1992, 7:1564-1583.
21. Sakai M. The Meyer hardness: a measure for plasticity?. J Mater Res 1999, 14:3630-3639.
22. Oyen M.L. Nanoindentation hardness of mineralized tissues. J Biomech 2006, 39:2699-2702.
23. Donnelly E., Baker S.P., Boskey A.L., van der Meulen M.C. Effects of surface roughness and maximum load on the mechanical properties of cancellous bone measured by nanoindentation. J Biomed Mater Res A 2006, 77:426-435.
24. Hoffler C.E., Guo X.E., Zysset P.K., Goldstein S.A. An application of nanoindentation technique to measure bone tissue Lamellae properties. J Biomech Eng 2005, 127:1046-1053.
25. Lucas B.N., Oliver W.C., Pharr G.M., Loubet J.-L. Time-dependent deformation during indentation testing. Mater Res Soc Symp Proc 1996, 436.
26. Zysset P.K., Guo X.E., Hoffler C.E., Moore K.E., Goldstein S.A. Mechanical properties of human trabecular bone lamellae quantified by nanoindentation. Technol Health Care 1998, 6:429-432.
27. Kono R. The dynamic bulk viscosity of polystyrene and polymethyl methacrylate. J Physical Soc Japan 1960, 15:718-725.
28. Ciarelli T.E., Fyhrie D.P., Parfitt A.M. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 2003, 32:311-315.
29. Hengsberger S., Kulik A., Zysset P. Nanoindentation discriminates the elastic properties of individual human bone lamellae under dry and physiological conditions. Bone 2002, 30:178-184.
30. Skedros J.G., Bloebaum R.D., Bachus K.N., Boyce T.M. The meaning of graylevels in backscattered electron images of bone. J Biomed Mater Res 1993, 27:47-56.
31. Skedros J.G., Bloebaum R.D., Bachus K.N., Boyce T.M., Constantz B. Influence of mineral content and composition on graylevels in backscattered electron images of bone. J Biomed Mater Res 1993, 27:57-64.
32. Fratzl P. Bone fracture: when the cracks begin to show. Nat Mater 2008, 7:610-612.
33. Fratzl P., Gupta H.S., Fischer F.D., Kolednik O. Hindered crack propagation in materials with periodically varying Young's modulus - Lessons from biological materials. Adv Mater 2007, 19:2657-2661.
34. Gupta H.S., Stachewicz U., Wagermaier W., Roschger P., Wagner H.D., Fratzl P. Mechanical modulation at the lamellar level in osteonal bone. J Mater Res 2006, 21:1913-1921.
35. Peterlik H., Roschger P., Klaushofer K., Fratzl P. From brittle to ductile fracture of bone. Nat Mater 2006, 5:52-55.
36. Wang X., Zauel R.R., Rao D.S., Fyhrie D.P. Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology). Bone 2008, 42:1184-1192.
37. Boskey A.L., Spevak L., Weinstein R.S. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int 2009, 20:793-800.
38. Gourion-Arsiquaud S., Allen M.R., Burr D.B., Vashishth D., Tang S.Y., Boskey A.L. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 2010, 46:666-672.
39. Roschger P., Rinnerthaler S., Yates J., Rodan G.A., Fratzl P., Klaushofer K. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 2001, 29:185-191.
40. Zoehrer R., Roschger P., Paschalis E.P., Hofstaetter J.G., Durchschlag E., Fratzl P., et al. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 2006, 21:1106-1112.
41. Burr D.B., Diab T., Koivunemi A., Koivunemi M., Allen M.R. Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk. J Orthop Res 2009, 27:1288-1292.
42. Allen M.R., Reinwald S., Burr D.B. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Calcif Tissue Int 2008, 82:354-360.
43. Allen M.R., Iwata K., Phipps R., Burr D.B. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 2006, 39:872-879.
44. Allen M.R., Burr D.B. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res 2007, 22:1759-1765.
45. Wang X., Allen M.R., Burr D.B., Lavernia E.J., Jeremic B., Fyhrie D.P. Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. Bone 2008, 43:775-780.
46. Wang X., Sudhaker Rao D., Ajdelsztajn L., Ciarelli T.E., Lavernia E.J., Fyhrie D.P. Human iliac crest cancellous bone elastic modulus and hardness differ with bone formation rate per bone surface but not by existence of prevalent vertebral fracture. J Biomed Mater Res B Appl Biomater 2008, 85:68-77.
47. Donnelly E., Boskey A.L., Baker S.P., van der Meulen M.C. Effects of tissue age on bone tissue material composition and nanomechanical properties in the rat cortex. J Biomed Mater Res A 2009, 92:1048-1056.
48. Smith L.J., Schirer J.P., Fazzalari N.L. The role of mineral content in determining the micromechanical properties of discrete trabecular bone remodeling packets. J Biomech 2010, 43:144-149.
49. Mittra E., Akella S., Qin Y.X. The effects of embedding material, loading rate and magnitude, and penetration depth in nanoindentation of trabecular bone. J Biomed Mater Res A 2006, 79:86-93.
50. Jepsen K.J., Goldstein S.A., Kuhn J.L., Schaffler M.B., Bonadio J. Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res 1996, 14:493-499.
51. Zioupos P., Currey J.D. Changes in the stiffness, strength, and toughness of human cortical bone with age. Bone 1998, 22:57-66.